The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Blueprint Medicines Corp. / See Company Profile

Financing / Public offering nets $327.7mm for Blueprint Medicines / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Apr. 2, 2019

Alliance / CStone gains rights to Blueprint's cancer candidates / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 5, 2018

Alliance / Blueprint signs on its first Big Pharma partner Roche in immuno-oncology deal / Strategic Transactions / Deal Date: Mar. 1, 2016 / Update Date: Jun. 1, 2018

Histogenics Corp. / See Company Profile

Acquisition / Histogenics, Ocugen reverse merge to create public ophthalmic-focused gene therapy development firm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 8, 2019

Financing / Histogenics nets $15.8mm in FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 8, 2018

Financing / Histogenics nets $5.9mm via FOPO / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 26, 2018

BeiGene Ltd. / See Company Profile

Alliance / BioAtla and BeiGene co-develop CTLA4 inhibitor; BeiGene gets exclusive global rights / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 10, 2019

Alliance / Ambrx and BeiGene pen biologics development and licensing agreement / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 8, 2019

Alliance / BeiGene gets exclusive rights to ZymeWorks' HER2-targeted bispecific candidates / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 29, 2018


Medical Devices

Email Alert | RSS Feed

Smith & Nephew PLC / See Company Profile

Acquisition / Smith & Nephew acquires pressure injury prevention and monitoring device firm Leaf Healthcare / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 2, 2019

Acquisition / Smith & Nephew acquires meniscal repair system maker Ceterix Orthopaedics for up to $105mm / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Apr. 2, 2019

Acquisition / Smith & Nephew acquires Brainlab's orthopedic joint reconstruction business / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 13, 2019

Cerevast Medical Inc. / See Company Profile

Alliance / Cerevast, Lantheus sign deal for retinal vein occlusion device / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Alliance / Cerevast licenses ultrasound neuromodulation technology from Arizona State / Strategic Transactions / Deal Date: Aug. 1, 2016 / Publish Date: Sep. 16, 2016

Acquisition / Microbix Biosystems buys ImaRx's urokinase business / Strategic Transactions / Deal Date: Sep. 1, 2008 / Update Date: Jun. 1, 2009

Endologix Inc. / See Company Profile

Financing / EndoLogix nets $51mm via FOPO / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 3, 2019

Financing / EndoLogix enters $170mm credit facility with Deerfield Management / Strategic Transactions / Deal Date: Apr. 1, 2017 / Update Date: Apr. 1, 2019

Financing / Endologix nets $19.8mm via FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Nov. 1, 2018


In Vitro Diagnostics

Email Alert | RSS Feed

NanoString Technologies Inc. / See Company Profile

Financing / NanoString nets $54mm through public offering / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 22, 2019

Financing / NanoString nets $56.7mm though public stock sale / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 22, 2017

Alliance / HalioDx, NanoString develop gene expression assays for immunotherapies / Strategic Transactions / Deal Date: Apr. 1, 2016 / Publish Date: Sep. 20, 2016

Inivata Ltd. / See Company Profile

Financing / Inivata raises $52.6mm via Series B round / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Apr. 5, 2019

Financing / Inivata raises £31.5mm through Series A round / Strategic Transactions / Deal Date: Jan. 1, 2016 / Publish Date: Jan. 27, 2016

Financing / Inivata closes £4mm seed round / Strategic Transactions / Deal Date: Sep. 1, 2014 / Publish Date: Jan. 12, 2015

Curetis NV / See Company Profile

Alliance / A. Menarini gets license to Curetis' Unyvero platform / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 27, 2019

Financing / Curetis nets €7.3mm via PIPE / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 13, 2018

Financing / Curetis secures up to €20mm in convertible debt financing / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 16, 2018


Pharmaceuticals

Email Alert | RSS Feed

SpringWorks Therapeutics Inc. / See Company Profile

Financing / SpringWorks raises $125mm in Series B round / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 2, 2019

Alliance / BeiGene and SpringWorks enter trial collaboration for solid tumors / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 10, 2018

Financing / SpringWorks launches, raises $103mm in Series A funding / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 25, 2017

Ironwood Pharmaceuticals Inc. / See Company Profile

Acquisition / Ironwood spins off Cyclerion / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Financing / Ironwood nets $292mm through convertible notes sale / Strategic Transactions / Deal Date: Jun. 1, 2015 / Update Date: Apr. 1, 2019

Alliance / Allergan/Ironwood settle generic Linzess patent litigation with Mylan / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 10, 2019

NGM Biopharmaceuticals Inc. / See Company Profile

Financing / NGM completes $61mm private placement to Merck, concurrent with IPO / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 5, 2019

Alliance / Merck invests in NGM, gets options to license new biologics / Strategic Transactions / Deal Date: Feb. 1, 2015 / Update Date: Apr. 1, 2019

Financing / NGM Biopharmaceuticals nets $99.2mm via IPO / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Oct. 9, 2018

Biotechnology

Biotechnology

Email Alert | RSS Feed

Blueprint Medicines Corp. / See Company Profile

Financing / Public offering nets $327.7mm for Blueprint Medicines / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Apr. 2, 2019

Alliance / CStone gains rights to Blueprint's cancer candidates / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 5, 2018

Alliance / Blueprint signs on its first Big Pharma partner Roche in immuno-oncology deal / Strategic Transactions / Deal Date: Mar. 1, 2016 / Update Date: Jun. 1, 2018

Histogenics Corp. / See Company Profile

Acquisition / Histogenics, Ocugen reverse merge to create public ophthalmic-focused gene therapy development firm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 8, 2019

Financing / Histogenics nets $15.8mm in FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 8, 2018

Financing / Histogenics nets $5.9mm via FOPO / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 26, 2018

BeiGene Ltd. / See Company Profile

Alliance / BioAtla and BeiGene co-develop CTLA4 inhibitor; BeiGene gets exclusive global rights / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 10, 2019

Alliance / Ambrx and BeiGene pen biologics development and licensing agreement / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 8, 2019

Alliance / BeiGene gets exclusive rights to ZymeWorks' HER2-targeted bispecific candidates / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 29, 2018

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Smith & Nephew PLC / See Company Profile

Acquisition / Smith & Nephew acquires pressure injury prevention and monitoring device firm Leaf Healthcare / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 2, 2019

Acquisition / Smith & Nephew acquires meniscal repair system maker Ceterix Orthopaedics for up to $105mm / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Apr. 2, 2019

Acquisition / Smith & Nephew acquires Brainlab's orthopedic joint reconstruction business / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 13, 2019

Cerevast Medical Inc. / See Company Profile

Alliance / Cerevast, Lantheus sign deal for retinal vein occlusion device / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Alliance / Cerevast licenses ultrasound neuromodulation technology from Arizona State / Strategic Transactions / Deal Date: Aug. 1, 2016 / Publish Date: Sep. 16, 2016

Acquisition / Microbix Biosystems buys ImaRx's urokinase business / Strategic Transactions / Deal Date: Sep. 1, 2008 / Update Date: Jun. 1, 2009

Endologix Inc. / See Company Profile

Financing / EndoLogix nets $51mm via FOPO / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 3, 2019

Financing / EndoLogix enters $170mm credit facility with Deerfield Management / Strategic Transactions / Deal Date: Apr. 1, 2017 / Update Date: Apr. 1, 2019

Financing / Endologix nets $19.8mm via FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Nov. 1, 2018

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

NanoString Technologies Inc. / See Company Profile

Financing / NanoString nets $54mm through public offering / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 22, 2019

Financing / NanoString nets $56.7mm though public stock sale / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 22, 2017

Alliance / HalioDx, NanoString develop gene expression assays for immunotherapies / Strategic Transactions / Deal Date: Apr. 1, 2016 / Publish Date: Sep. 20, 2016

Inivata Ltd. / See Company Profile

Financing / Inivata raises $52.6mm via Series B round / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Apr. 5, 2019

Financing / Inivata raises £31.5mm through Series A round / Strategic Transactions / Deal Date: Jan. 1, 2016 / Publish Date: Jan. 27, 2016

Financing / Inivata closes £4mm seed round / Strategic Transactions / Deal Date: Sep. 1, 2014 / Publish Date: Jan. 12, 2015

Curetis NV / See Company Profile

Alliance / A. Menarini gets license to Curetis' Unyvero platform / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 27, 2019

Financing / Curetis nets €7.3mm via PIPE / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 13, 2018

Financing / Curetis secures up to €20mm in convertible debt financing / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 16, 2018

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

SpringWorks Therapeutics Inc. / See Company Profile

Financing / SpringWorks raises $125mm in Series B round / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 2, 2019

Alliance / BeiGene and SpringWorks enter trial collaboration for solid tumors / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 10, 2018

Financing / SpringWorks launches, raises $103mm in Series A funding / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 25, 2017

Ironwood Pharmaceuticals Inc. / See Company Profile

Acquisition / Ironwood spins off Cyclerion / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Financing / Ironwood nets $292mm through convertible notes sale / Strategic Transactions / Deal Date: Jun. 1, 2015 / Update Date: Apr. 1, 2019

Alliance / Allergan/Ironwood settle generic Linzess patent litigation with Mylan / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 10, 2019

NGM Biopharmaceuticals Inc. / See Company Profile

Financing / NGM completes $61mm private placement to Merck, concurrent with IPO / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 5, 2019

Alliance / Merck invests in NGM, gets options to license new biologics / Strategic Transactions / Deal Date: Feb. 1, 2015 / Update Date: Apr. 1, 2019

Financing / NGM Biopharmaceuticals nets $99.2mm via IPO / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Oct. 9, 2018

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel